Signing Day Sports, Inc. has filed Prospectus Supplement No. 2 with the SEC, detailing the authorization of up to 4,661,102 shares of common stock. This supplement, dated February 29, 2024, follows the initial prospectus dated February 14, 2024, and includes information from the company's Form 8-K filed on February 28, 2024. The company's common stock, traded under the symbol 'SGN' on NYSE American, was last reported at $0.6999 per share on February 28, 2024. As an emerging growth and smaller reporting company, Signing Day Sports has opted for reduced public company reporting requirements. The filing also reports the approval of amendments to the company's certificate of incorporation to authorize 15,000,000 shares of 'blank-check preferred stock' and the resignation of Richard Symington as President, Chief Technology Officer, and board member. Additionally, stockholders approved proposals to amend the 2022 Equity Incentive Plan, increasing the number of shares available for issuance, and to approve the issuance of up to $25,000,000 in common stock under an equity line financing arrangement.

Signing Day Sports, Inc. has filed Prospectus Supplement No. 2 with the SEC, detailing the authorization of up to 4,661,102 shares of common stock. This supplement, dated February 29, 2024, follows the initial prospectus dated February 14, 2024, and includes information from the company's Form 8-K filed on February 28, 2024. The company's common stock, traded under the symbol 'SGN' on NYSE American, was last reported at $0.6999 per share on February 28, 2024. As an emerging growth and smaller reporting company, Signing Day Sports has opted for reduced public company reporting requirements. The filing also reports the approval of amendments to the company's certificate of incorporation to authorize 15,000,000 shares of 'blank-check preferred stock' and the resignation of Richard Symington as President, Chief Technology Officer, and board member. Additionally, stockholders approved proposals to amend the 2022 Equity Incentive Plan, increasing the number of shares available for issuance, and to approve the issuance of up to $25,000,000 in common stock under an equity line financing arrangement.